Becton Dickinson EBITDA Margin 2012-2026 | BDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Becton Dickinson (BDX) over the last 10 years. The current EBITDA margin for Becton Dickinson as of June 30, 2026 is
Unlock Macrotrends Premium
Start 7-Day Free Trial
Becton Dickinson EBITDA Margin Historical Data
Date
TTM Revenue
TTM EBITDA
EBITDA Margin
2026-06-30
$22.42B
$4.76B
21.24%
2026-03-31
$22.16B
$4.85B
21.88%
2025-12-31
$21.92B
$5.14B
23.46%
2025-09-30
$21.84B
$5.04B
23.08%
2025-06-30
$19.81B
$4.49B
22.68%
2025-03-31
$20.08B
$4.35B
21.66%
2024-12-31
$20.64B
$4.75B
22.99%
2024-09-30
$20.18B
$4.68B
23.21%
2024-06-30
$19.83B
$4.41B
22.25%
2024-03-31
$19.72B
$4.36B
22.11%
2023-12-31
$19.49B
$4.25B
21.78%
2023-09-30
$19.37B
$4.40B
22.71%
2023-06-30
$19.05B
$4.53B
23.79%
2023-03-31
$18.81B
$4.50B
23.95%
2022-12-31
$18.74B
$4.43B
23.63%
2022-09-30
$18.87B
$4.51B
23.91%
2022-06-30
$18.41B
$4.11B
22.31%
2022-03-31
$18.38B
$4.04B
22.01%
2021-12-31
$18.53B
$3.92B
21.16%
2021-09-30
$19.13B
$4.48B
23.42%
2021-06-30
$18.57B
$4.01B
21.60%
2021-03-31
$17.82B
$3.88B
21.76%
2020-12-31
$17.16B
$3.79B
22.10%
2020-09-30
$16.07B
$3.03B
18.83%
2020-06-30
$16.92B
$3.50B
20.66%
2020-03-31
$17.41B
$3.80B
21.83%
2019-12-31
$17.36B
$3.60B
20.71%
2019-09-30
$17.29B
$4.01B
23.21%
2019-06-30
$17.11B
$4.49B
26.25%
2019-03-31
$17.04B
$4.37B
25.65%
2018-12-31
$17.06B
$4.41B
25.85%
2018-09-30
$15.98B
$3.49B
21.82%
2018-06-30
$14.75B
$3.12B
21.17%
2018-03-31
$13.50B
$2.10B
15.54%
2017-12-31
$12.25B
$2.06B
16.85%
2017-09-30
$12.09B
$2.61B
21.58%
2017-06-30
$12.16B
$2.20B
18.12%
2017-03-31
$12.32B
$2.94B
23.83%
2016-12-31
$12.42B
$2.98B
23.96%
2016-09-30
$12.48B
$2.54B
20.38%
2016-06-30
$12.31B
$2.78B
22.61%
2016-03-31
$12.23B
$2.43B
19.88%
2015-12-31
$11.22B
$2.12B
18.88%
2015-09-30
$10.28B
$1.97B
19.11%
2015-06-30
$9.42B
$1.91B
20.21%
2015-03-31
$8.46B
$2.06B
24.30%
2014-12-31
$8.48B
$2.14B
25.18%
2014-09-30
$8.45B
$2.17B
25.67%
2014-06-30
$8.35B
$1.84B
22.01%
2014-03-31
$8.24B
$1.79B
21.77%
2013-12-31
$8.17B
$1.80B
22.03%
2013-09-30
$8.05B
$1.80B
22.36%
2013-06-30
$7.92B
$2.10B
26.49%
2013-03-31
$7.85B
$2.13B
27.09%
2012-12-31
$7.78B
$2.12B
27.26%
2012-09-30
$7.71B
$2.07B
26.84%
2012-06-30
$7.61B
$2.05B
26.90%
2012-03-31
$7.58B
$2.04B
26.94%
2011-12-31
$7.57B
$2.09B
27.65%
2011-09-30
$7.58B
$2.16B
28.48%
2011-06-30
$7.34B
$2.10B
28.54%
2011-03-31
$7.22B
$2.08B
28.82%
2010-12-31
$7.10B
$2.06B
28.98%
2010-09-30
$7.12B
$2.07B
29.11%
2010-06-30
$7.22B
$2.14B
29.57%
2010-03-31
$7.21B
$2.13B
29.58%
2009-12-31
$7.14B
$2.07B
29.03%
2009-09-30
$6.99B
$2.05B
29.40%
2009-06-30
$6.86B
$2.02B
29.42%
2009-03-31
$6.89B
$2.00B
28.99%
2008-12-31
$6.91B
$2.02B
29.19%
2008-09-30
$6.90B
$1.96B
28.41%
2008-06-30
$6.88B
$1.95B
28.33%
2008-03-31
$6.66B
$1.86B
27.92%
2007-12-31
$6.49B
$1.79B
27.58%
2007-09-30
$6.28B
$1.63B
25.88%
2007-06-30
$6.17B
$1.58B
25.63%
2007-03-31
$6.00B
$1.53B
25.48%
2006-12-31
$5.85B
$1.45B
24.79%
2006-09-30
$5.74B
$1.54B
26.91%
2006-06-30
$5.58B
$1.54B
27.52%
2006-03-31
$5.51B
$1.51B
27.38%
2005-12-31
$5.45B
$1.51B
27.76%
2005-09-30
$5.34B
$1.45B
27.09%
2005-06-30
$5.29B
$1.40B
26.48%
2005-03-31
$5.15B
$1.26B
24.54%
2004-12-31
$5.04B
$1.23B
24.47%
2004-09-30
$4.94B
$1.14B
23.18%
2004-06-30
$4.79B
$1.11B
23.13%
2004-03-31
$4.72B
$1.15B
24.47%
2003-12-31
$4.60B
$1.11B
24.24%
2003-09-30
$4.46B
$1.10B
24.60%
2003-06-30
$4.36B
$1.05B
24.16%
2003-03-31
$4.19B
$1.03B
24.62%
2002-12-31
$4.07B
$1.00B
24.51%
2002-09-30
$3.96B
$0.97B
24.55%
2002-06-30
$3.94B
$0.96B
24.42%
2002-03-31
$3.89B
$0.96B
24.74%
2001-12-31
$3.83B
$0.96B
25.11%
2001-09-30
$3.75B
$0.94B
25.20%
2001-06-30
$3.68B
$0.91B
24.82%
2001-03-31
$3.65B
$0.89B
24.50%
2000-12-31
$3.62B
$0.87B
23.88%
2000-09-30
$3.62B
$0.86B
23.80%
2000-06-30
$3.60B
$0.84B
23.39%
2000-03-31
$3.56B
$0.81B
22.73%
1999-12-31
$3.51B
$0.80B
22.81%
1999-09-30
$3.42B
$0.78B
22.82%
1999-06-30
$3.36B
$0.79B
23.37%
1999-03-31
$3.32B
$0.75B
22.65%
1998-12-31
$3.18B
$0.74B
23.30%
1998-09-30
$3.12B
$0.72B
23.23%
1998-06-30
$3.02B
$0.71B
23.42%
1998-03-31
$2.90B
$0.71B
24.41%
1997-12-31
$2.86B
$0.68B
23.80%
1997-09-30
$2.81B
$0.66B
23.48%
1997-06-30
$2.79B
$0.79B
28.43%
1997-03-31
$2.78B
$0.76B
27.20%
1996-12-31
$2.79B
$0.70B
24.98%
1996-09-30
$2.77B
$0.63B
22.82%
1996-06-30
$2.76B
$0.43B
15.43%
1996-03-31
$2.77B
$0.42B
15.01%
1995-12-31
$2.76B
$0.41B
14.82%
1995-09-30
$2.71B
$0.40B
14.64%
1995-06-30
$2.71B
$0.40B
14.59%
1995-03-31
$2.66B
$0.38B
14.30%
1994-12-31
$2.60B
$0.37B
14.12%
1994-09-30
$2.56B
$0.36B
13.91%
1994-06-30
$2.51B
$0.32B
12.71%
1994-03-31
$2.48B
$0.31B
12.37%
1993-12-31
$2.46B
$0.29B
11.92%
1993-09-30
$2.47B
$0.30B
12.05%
1993-06-30
$2.48B
$0.32B
13.02%
1993-03-31
$2.45B
$0.33B
13.49%
1992-12-31
$2.43B
$0.34B
13.94%
1992-09-30
$2.37B
$0.33B
13.91%
1992-06-30
$2.26B
$0.31B
13.84%
1992-03-31
$2.23B
$0.30B
13.66%
1991-12-31
$2.19B
$0.30B
13.87%
1991-09-30
$2.17B
$0.31B
14.46%
1991-06-30
$2.16B
$0.32B
14.95%
1991-03-31
$2.10B
$0.32B
15.17%
1990-12-31
$2.07B
$0.31B
15.19%
1990-09-30
$2.01B
$0.31B
15.14%
1990-06-30
$1.95B
$0.29B
14.69%
1990-03-31
$1.89B
$0.27B
14.42%
1989-12-31
$1.84B
$0.26B
14.11%
1989-09-30
$1.81B
$0.26B
14.07%
1989-06-30
$1.68B
$0.24B
13.97%
1989-03-31
$1.72B
$0.24B
14.15%
1988-12-31
$1.72B
$0.24B
14.03%
1988-09-30
$1.71B
$0.24B
13.98%
1988-06-30
$1.80B
$0.25B
13.98%
1988-03-31
$1.71B
$0.24B
14.04%
1987-12-31
$1.64B
$0.23B
14.06%
1987-09-30
$1.58B
$0.22B
13.90%
Sector
Industry
Market Cap
Revenue
Medical Medical & Dental Supplies $51.228B
$21.840B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
